CRIS Q3 2022 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-7.0% YoY

Gross Profit

$3M97.8% margin

Operating Income

-$13M-446.2% margin

Net Income

-$13M-470.6% margin

EPS (Diluted)

$-2.98

QoQ Revenue Growth

+18.1%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$123M

Total Liabilities

$67M

Stockholders' Equity

$56M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-7.0%
Gross Profit	$3M	$3M	-4.3%
Operating Income	-$13M	-$10M	-25.5%
Net Income	-$13M	-$11M	-20.3%

Revenue Segments

Gross Royalty Revenue

$3M101%

Contra Revenue

-$18,000-1%